NEW YORK (GenomeWeb) – KromaTid today announced a Japanese distribution agreement with Tokyo Future Style for its directional Genomic Hybridization (dGH) and Pinpoint FISH products and services.

"Tokyo Future Style has a very focused approach to the Japanese market that we feel makes them a great fit for selling our products and services," KromaTid CEO Alex Vodenlich said in a statement.

The firm's dGH genomic imaging assay is able to determine DNA sequence, location, and orientation data in a single test, the firm said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.